Phosphoinositide signaling disorders in human diseases (Q35163916)

6 August 2017

1 reference

title

Phosphoinositide signaling disorders in human diseases (English)

1 reference

6 August 2017

Caroline Pendaries

1

1 reference

6 August 2017

Hélène Tronchère

series ordinal

2

1 reference

6 August 2017

Monique Plantavid

series ordinal

3

1 reference

6 August 2017

Bernard Payrastre

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

546

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

25-31

1 reference

Phosphoinositides: key players in cell signalling, in time and space.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Phosphoinositides and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Inositol trisphosphate and diacylglycerol: two interacting second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The role of phosphoinositide 3-kinase lipid products in cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Phosphoinositide-binding domains: Functional units for temporal and spatial regulation of intracellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Thrombin stimulation of platelets causes an increase in phosphatidylinositol 5-phosphate revealed by mass assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Phosphoinositide signaling and the regulation of membrane trafficking in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

SNX3 regulates endosomal function through its PX-domain-mediated interaction with PtdIns(3)P

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Interaction of the EEA1 FYVE finger with phosphatidylinositol 3-phosphate and early endosomes. Role of conserved residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Phosphoinositide regulation of the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Oncogenes and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

PTEN: a tumour suppressor that functions as a phospholipid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The lipid phosphatase SHIP2 controls insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Functional redundancy in the myotubularin family

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Phosphatidylinositol signalling reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Cytoskeletal rearrangements and the functional role of T-plastin during entry of Shigella flexneri into HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

A role for phosphoinositide 3-kinase in bacterial invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Internalin B activates nuclear factor-kappa B via Ras, phosphoinositide 3-kinase, and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The diversity and possible functions of the inositol polyphosphate 5-phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

The Listeria monocytogenes protein InlB is an agonist of mammalian phosphoinositide 3-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

IpgD, a protein secreted by the type III secretion machinery of Shigella flexneri, is chaperoned by IpgE and implicated in entry focus formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

Identification of a PTEN mutation in a family with Cowden syndrome and Bannayan-Zonana syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2803%2900437-X

10.1016/S0014-5793(03)00437-X

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference